Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Vaccine|March 10, 2015
Vaccine coverage estimation using a computerized vaccination registry with potential underreporting and a seroprevalence studyLina Pérez Breva, Javier Díez Domingo, Miguel Ángel Martínez Beneito, et al.
BMC Infectious Diseases|October 8, 2013
Herpes zoster surveillance using electronic databases in the Valencian Community (Spain)Nuria Morant-Talamante, Javier Diez-Domingo, Sergio Martínez-Úbeda, et al.
British Journal of Clinical Pharmacology|September 2, 2025
Why and how do we perform physical examination(s) in clinical trials? A use case of drug intervention trials in type 2 diabetes mellitusJulia Kopanz, Amy Rogers, Lina Pérez-Breva, et al.
BMC Infectious Diseases|June 3, 2014
Optimizing strategies for meningococcal C disease vaccination in Valencia (Spain)Lina Pérez-Breva, Rafael J Villanueva, Javier Villanueva-Oller, et al.
Journal of Medical Internet Research|July 9, 2026
Addressing the Key Challenges of Decentralized Clinical Trials in Europe: Multistakeholder Perspective Delphi StudyCarlos Murciano-Gamborino, Lina Pérez-Breva, Amos J de Jong, et al.
Vaccine|April 26, 2017
Seroprevalence of antibodies against serogroup C meningococci in the region of Valencia, Spain: Impact of meningococcal C conjugate vaccinationLina Pérez-Breva, Raquel Abad-Torreblanca, Miguel Ángel Martínez-Beneito, et al.
Clinical Pharmacology and Therapeutics|October 2, 2025
Selecting and Preparing Clinical Sites for the Successful Conduct of Decentralized Clinical Trial Activities-Findings From the Trials@Home RADIAL Proof-of-Concept TrialKatarzyna Lipinska, Danny van Weelij, Bart Lagerwaard, et al.
Influenza and Other Respiratory Viruses|February 5, 2024
The respiratory syncytial virus prefusion F protein vaccine attenuates the severity of respiratory syncytial virus-associated disease in breakthrough infections in adults ≥60 years of ageDesmond Curran, Sean Matthews, Eliazar Sabater Cabrera, et al.
Open Forum Infectious Diseases|April 17, 2023
Respiratory Syncytial Virus Disease Burden in Community-Dwelling and Long-Term Care Facility Older Adults in Europe and the United States: A Prospective StudySílvia Narejos Pérez, Josep María Ramón Torrell, Airi Põder, et al.
Clinical Epidemiology|March 27, 2026
Harmonizing Case Validation for Vaccine Safety in Real-World Data: The VAC4EU ExperienceAmirreza Dehghan Tarazjani, Daniel Weibel, Taylor Aurelius, et al.
Pageof 2